Callan Family Office »

Regeneron Pharmaceuticals shares owned by Callan Family Office

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Callan Family Office from 13F filings

Historical chart of Callan Family Office investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Callan Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Callan Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.8M 6.7k 562.26
2025-06-30 $3.2M 6.0k 525.00
2025-03-31 $1.2M 1.9k 634.23
2024-12-31 $1.1M 1.6k 712.33
2023-03-31 $646k 786 821.67